Mammography

Three facilities share what is working best as they begin to screen more patients.

Diagnostic Imaging's Weekly Scan: June 12, 2020

More than 75 percent of breast imaging environments are close to re-capturing pre-pandemic imaging volumes.

Diagnostic Imaging's Weekly Scan: May 22, 2020

Diagnostic Imaging talks with Laura Heacock, M.D., from NYU Langone Health about what’s keeping abbreviated MRI from wider implementation.

Existing protocol to re-assess women after six months is appropriate; imaging can identify cancers that have spread to lymph nodes.

Study finds risk reduction attributed to screening efforts, not advanced therapies.

Research provides evidence for imaging mastectomy site during opposite-breast cancer screening.

Radiologists can use online videos as a way to correct inaccurate breast cancer screening messages.

From detecting breast density and reducing image file sizes to improving cancer detection and creating new risk models, AI is significantly impacting breast imaging.

With more details about benefits and harms of annual screening, fewer women opt for the study.

Eight recommendations released for imaging women post-mastectomy and breast reconstruction.

Diagnostic Imaging's Week in Review: April 10, 2020.

Insights from industry experts on ways their departments have changed during the pandemic.

Society categorizes patients based on risk associated with delaying services.

Study shows three risk factors for breast cancer can be passed down through genes.

Research reveals half of radiologists saw no change in their recall rates.

Shortened protocol identifies more cancers than ultrasound or mammography.

Agency instructs imaging centers on possible closures and surveys.

Recommendations touch on patient care and infection control.

Preference for emailed video offers benefits to both patient and radiologist.

Digital breast tomosynthesis identifies more aggressive cancers with fewer false positives than traditional mammography over the long term.

ScreenPoint Medical receives greenlight for Transpara™ 1.6.0. to reduce read times.

Continued screening in older age doesn’t provide greater survival benefit.